减少CT静脉对比剂使用:一项具有持续效果的全卫生系统干预
该回顾性研究纳入大型卫生系统12个中心17个月内所有CT检查,于2022年5月23日对13种CT检查实施标准化对比剂剂量。干预前每次检查平均对比剂剂量为89.3 mL,标准化后降至78.0 mL(降幅12.7%,P < .001),干预后期间为80.4 mL(降幅10.0%,P < .001),12个中心中9个在干预后维持了降低后的剂量。
要点
- 标准化对比剂剂量方案实施后,每次CT检查平均对比剂剂量从89.3 mL降至78.0 mL(降幅12.7%,P < .001)。
- 剂量降低效果持续至干预后期间,平均剂量为80.4 mL(较干预前降幅10.0%,P < .001)。
- 12个中心中9个在干预后期间维持了降低后的对比剂剂量。
核心结论
- 对常用CT检查实施标准化对比剂剂量方案,可使对比剂使用量快速下降,且该效果持续超过1年。
研究设计与样本
- 回顾性研究,纳入大型卫生系统12个中心17个月内所有接受CT检查的患者,于2022年5月23日对13种CT检查实施标准化对比剂剂量,比较干预前(2022年1月1日至2022年5月22日)、干预期间(2022年5月23日至2022年9月11日)和干预后(2022年9月12日至2023年6月30日)三个时段的每次CT检查平均对比剂使用量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the volume of intravenous iodinated contrast media used for CT before, during, and after the global iohexol shortage over a total of 17 months at a multisite health system.
METHODS: This retrospective study included all patients who underwent CT at a large health system with 12 sites. Standardized contrast doses for 13 CT examinations were implemented May 23, 2022. Mean contrast utilization per CT encounter was compared between three periods (preintervention: January 1, 2022, to May 22, 2022; intervention: May 23, 2022, to September 11, 2022; postintervention: September 12, 2022, to June 30, 2023). Contrast doses and CT encounter data were extracted from the enterprise data warehouse. Categorical variables were compared with a χ2 test, and continuous variables were compared with a two-tailed t test. Multivariable linear regression assessed significance, with coefficients noted to determine magnitude and direction of effect.
RESULTS: Preintervention, there were 152,009 examinations (87,722 with contrast [57.7%]); during the intervention, there were 120,031 examinations (63,217 with contrast [52.7%]); and during the postintervention, there were 341,862 examinations (194,231 with contrast [56.8%]). Preintervention, mean contrast dose was 89.3 mL per examination, which decreased to 78.0 mL after standardization (Δ of -12.7%) (P < .001). This decrease continued throughout the intervention and persisted in the postintervention period (80.4 mL; Δ -10.0%, P < .001). On multivariable analysis, patient weight, sex, and performing site were all associated with variations in contrast dose. Most but not all sites (9 of 12) sustained the decreased contrast media dose in the postintervention period.
DISCUSSION: Implementing standardized contrast media dosing for commonly performed CT examinations led to a rapid decrease in contrast media utilization, which persisted over 1 year.
引用
- Isabelle M, Lacson R, Johnston H, et al. Reducing Intravenous Contrast Utilization for CT: A Health System-Wide Intervention With Sustained Impact. J Am Coll Radiol. 2024. PMID: 39142545. doi:10.1016/j.jacr.2024.07.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。